Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. - Wikidata - awgldk - TriplyDB

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.

http://www.wikidata.org/entity/Q33245287

about

EphA2 is an essential mediator of UV radiation-induced apoptosis EphA receptor signaling--complexity and emerging themes Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways Melanoma: from mutations to medicine Molecular ultrasound assessment of tumor angiogenesis Autosomal recessive congenital cataract linked to EPHA2 in a consanguineous Pakistani family.k-Nearest neighbor models for microarray gene expression analysis and clinical outcome prediction.Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.Soluble ephrin a1 is necessary for the growth of HeLa and SK-BR3 cells Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin.A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1.In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme ICan: an integrated co-alteration network to identify ovarian cancer-related genes EphA2 is a critical oncogene in melanoma.Eph receptors and ephrins as targets for cancer therapy.Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis Screening and structural evaluation of deleterious Non-Synonymous SNPs of ePHA2 gene involved in susceptibility to cataract formation.Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis.Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma.EphA8 is a prognostic marker for epithelial ovarian cancer.Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes.Ephrin expression and function in cancer.The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.Eph family co-expression patterns define unique clusters predictive of cancer phenotype.Gene expression profiling of human mesenchymal stem cells for identification of novel markers in early- and late-stage cell culture.Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer.EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability.Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck.Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29).EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor.Potential molecular signatures in epithelial ovarian cancer by genome wide expression profiling.

P2860

Q24311103-1EA5DEA4-F7B6-40D2-98A0-09A179BA98A5 Q26864082-947AABEB-C218-4B68-A14B-936AE3B19735 Q27014964-ED5AAEC3-BC52-4B1B-BB8B-AB3E4B0E34F9 Q27024061-1A16648C-5C89-4BAD-804F-3A0E7F01ACE7 Q30474770-F1A1FA8E-D7E3-499F-8F6E-15F545238512 Q33758608-DEA08FCD-925C-44CE-8C9D-065A8260E35E Q34059963-890689A3-3A76-4CB0-9AFE-BAC56ADD68C4 Q34287768-AD6837ED-A964-4C14-9BF4-B42D6F5C03C2 Q34321468-83A69F98-30FC-4C39-9E80-4D2F4EDB4CB4 Q34416766-1A8DB68B-A2CB-4868-B0AC-E60F2E6291DD Q34512240-3E473D2A-95E2-4BC9-8628-D01039130467 Q34951859-61DF9FD7-C8DC-427B-A631-F9E6AE7F6862 Q35213374-4B0D0D5A-DE6C-4735-96C7-6D4857E539D0 Q35218960-67D5339C-19E3-4708-867E-58C578E392C0 Q35370195-1103FCD2-BCF4-474C-9EB5-DB8135AD3F20 Q35621005-9EA175C4-F19D-4782-8877-CC64EACA57F0 Q35666005-4F8DB64C-4377-4BA0-9962-5F4509BB108C Q35783568-2E7807B9-FBB4-41F6-950D-DA075793675A Q35919154-61444259-4588-48EF-9EE3-D089C42BB674 Q36054843-B833F353-3102-41EF-A6D2-D0748B8689B2 Q36100484-8ACD4567-9CEE-4AF5-89C8-1158EC9BA9C3 Q36484515-DAEA7778-29F8-4E36-9295-891EB4084847 Q36713605-2F3E3BDD-E03F-4B09-93EC-3D738C372AB9 Q37116330-D39142D4-30C0-4FCF-BADF-B4E2AB85FD64 Q37190444-0A1FA549-EA84-44BD-91BA-364B8426D4DC Q37429878-4BE318CA-5B19-4A6C-A1E7-2CED1B3EFC3D Q37658786-8FD61D8B-A3C5-4E02-9F29-2716A192B89E Q38006838-22156311-6319-4734-878B-200D722F6B91 Q38269791-6C3283E8-273E-4EB7-A067-5F8126439E23 Q38290120-0653B672-AEAA-4F77-8755-C0E3B06D20C9 Q38336376-256662A7-781E-4637-AC5D-0995AF305A87 Q38990966-25222592-90E4-4A23-81FB-64F2B2382C20 Q39442560-7CD253BE-CF47-4408-896D-39EF8A7DED69 Q39445033-C8DD3992-93DD-4598-8F8C-9A16515C54A7 Q39682934-F9B8124C-7CE6-405D-A435-1CCF57AEE1B5 Q42633983-535C610B-7187-4C6B-B282-F66BB7865704 Q46095419-D6936365-4E4F-4240-BABC-0DDEFD19C385 Q48012865-D3D99B52-AA06-49D0-86EE-3303979324F2

P2860

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.

http://www.wikidata.org/entity/Q33245287

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Over-expression of Eph and eph ...... lates with shortened survival.

@ast

Over-expression of Eph and eph ...... lates with shortened survival.

@en

type

label

Over-expression of Eph and eph ...... lates with shortened survival.

@ast

Over-expression of Eph and eph ...... lates with shortened survival.

@en

prefLabel

Over-expression of Eph and eph ...... lates with shortened survival.

@ast

Over-expression of Eph and eph ...... lates with shortened survival.

@en

P1433

Q33245287-033A2F1C-D031-4C17-9990-8A9E5C2B4F4F

P1476

Q33245287-15D1586D-9D98-4F57-BE44-9DCC8AE634C5

P2093

Q33245287-03AEE8C5-F99B-46DA-BFDA-8C01E767E725

Q33245287-11C0319D-F4CE-4C9B-997F-3ACE2BAAAA71

Q33245287-1C9485C5-B0A9-4BCD-8328-83B41B44227D

Q33245287-58E80BA3-150A-428C-97C9-E45DD3FCFF41

Q33245287-B0CCBF9F-CE1E-4FBE-9C52-5A969A9E5AEF

Q33245287-BEF7F273-34F1-4421-AC02-42AB0055C7E1

Q33245287-DD705B88-3896-47FF-9B5C-07B9CA0DA695

Q33245287-F8DDA07A-F9B2-497D-83A4-7C299747D33F

P2860

Q33245287-0E71660A-FE69-4C91-B0CB-192EE1626A97

Q33245287-13E79509-A6B5-4D48-90C9-300657AA5D58

Q33245287-14805708-09D8-4F88-98F9-FA60785FCD28

Q33245287-177EFDF3-AC2B-480C-9E48-A8129FC755BF

Q33245287-1FFABF8F-C6D8-4BA1-9010-ECA733F563BB

Q33245287-270F59C9-F405-4659-808D-EE5C68A09AAD

Q33245287-2D2F26EA-13AB-4759-BFE2-268E87C472F2

Q33245287-2E24F3F2-8F5C-495F-8371-CE9C457F939A

Q33245287-3A04B80D-3127-46FF-8005-1CCCE26D6FC4

Q33245287-53439798-779E-4745-9B72-D2FA612699D8

P2888

Q33245287-5C7FBE9F-C26A-4AA3-B025-250AED5F9B34

P304

Q33245287-9D562653-5554-4A59-A0C5-1344A9AA0523

P31

Q33245287-471B7207-3921-40EC-A093-34FB5FE36EDE

P356

Q33245287-80A08933-1D68-4F31-902D-C772961ADC9C

P407

Q33245287-329B6372-C9C9-45B2-B24E-5F9EF00E316C

P478

Q33245287-EA95195A-128D-419F-A8F1-AC2379A4C7B2

P50

Q33245287-2E7974A4-D6A4-47C3-95EB-8959EBDE7849

Q33245287-A35E64BB-1B14-4090-AC6B-F8FB7B7AE655

P577

Q33245287-0B0F6E75-85E4-40B8-90A2-2319638FC5F0

P5875

Q33245287-BF5D6A0B-DF31-45F5-BD0A-7DDDC722492D

P6179

Q33245287-C7C4354D-6324-4794-87B3-201BB7A4E9E6

P698

Q33245287-11D45301-2106-413A-A603-2FB3E73FE868

P921

Q33245287-6B3A34A6-0435-46AD-B98A-CD492CB8A8C0

P932

Q33245287-1AA61DC2-6619-4B03-B1FB-2DF58FF038EE

P356

1471-2407-6-144

P1433

P1476

Over-expression of Eph and eph ...... lates with shortened survival.

@en

P2093

Andrew W Boyd

http://www.w3.org/2001/XMLSchema#string

Douglas Lincoln

http://www.w3.org/2001/XMLSchema#string

Margaret Cummings

http://www.w3.org/2001/XMLSchema#string

Mark D Spanevello

http://www.w3.org/2001/XMLSchema#string

Nirmitha I Herath

http://www.w3.org/2001/XMLSchema#string

Sabe Sabesan

http://www.w3.org/2001/XMLSchema#string

Shannon Duffy

http://www.w3.org/2001/XMLSchema#string

Tanya Newton

http://www.w3.org/2001/XMLSchema#string

P2860

LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain

A tyrosine kinase profile of prostate carcinoma

Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer

Mechanisms and functions of Eph and ephrin signalling

Signals from Eph and ephrin proteins: a developmental tool kit

Coexpression of ephrin-Bs and their receptors in colon carcinoma

Characterization of the Epha1 receptor tyrosine kinase: expression in epithelial tissues

A novel putative tyrosine kinase receptor encoded by the eph gene

Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis

Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis

P2888

1471-2407-6-144

P304

144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-6-144

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Peter G. Parsons

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7044465

http://www.w3.org/2001/XMLSchema#string

P6179

1041912407

http://www.w3.org/2001/XMLSchema#string

P698

16737551

http://www.w3.org/2001/XMLSchema#string

P921

P932

1501040

http://www.w3.org/2001/XMLSchema#string